Outside of clinical trials, pre-licence access in the UK may theoretically occur via the MHRA's Early Access to Medicines Scheme (EAMS), though no such scheme for retatrutide is publicly available at the time of writing
Good sources are fruits, vegetables, whole grains, seeds and nuts
We list them by how common each is employed
Together, they work on two separate appetite-control systems at once GLP-1 and amylin which is why the combination outperforms either drug alone
Regulatory Status and Absence of Human Safety Data As of 2026, retatrutide has not received approval from the MHRA, FDA, EMA, or any other regulatory authority for human use
PROFESSOR LUIGI FONTANA, CHARLES PERKINS CENTRE, UNIVERSITY OF SYDNEY: There are no data in humans